This week, Speed Gel creator Scott Snyder participated in the 1st International Comprehensive Pain Management Conference in the United Arab Emirates. Snyder spoke to the conference about the Extemporaneous Compounding of Pain Medicines for Terminal Cancer Patients. As an expert in transdermal technology and treatment, Snyder shared his experiences with hundreds of other healthcare and medical professionals. Snyder emphasized that asking questions are key in compounding formulas for the treatment of patients pain.

“Better understanding a patients symptoms, the history of their pain, and the orientation of their pain can only assist us in providing better treatment for pain,” Snyder said. “As healthcare professionals, our goal is to alleviate a patients pain as much as possible. However, we first must understand it.”

Snyder’s new patented transdermal technology allows for site specific treatment of a patients pain. With proven ingredients that drive the medicine directly through the skin to the source of pain, Snyder is having higher success rates in alleviating pain. For more about Snyder’s presentation, go to: www.snydercenter.com